Nymox Pharmaceutical NYMXF
OTC NYMXF
$0.06 +0.03 (+100.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nymox Pharmaceutical (NYMXF) Current Debt (2023)

Updated

Analysis

Nymox Pharmaceutical (NYMXF) Current Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -4.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 64.00 Mn
10 Nymox Pharmaceutical 5.76 Mn 5.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 250,000.00
API Access

Nymox Pharmaceutical Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=NYMXF&period=max&api_key=YOUR_API_KEY